Citadel Investment Advisory, Inc. Enovis Corp Transaction History
Citadel Investment Advisory, Inc.
- $193 Million
- Q4 2024
A detailed history of Citadel Investment Advisory, Inc. transactions in Enovis Corp stock. As of the latest transaction made, Citadel Investment Advisory, Inc. holds 3,055 shares of ENOV stock, worth $111,874. This represents 0.07% of its overall portfolio holdings.
Number of Shares
3,055
Previous 3,197
4.44%
Holding current value
$111,874
Previous $137,000
2.19%
% of portfolio
0.07%
Previous 0.07%
Shares
10 transactions
Others Institutions Holding ENOV
# of Institutions
314Shares Held
60.6MCall Options Held
1.83MPut Options Held
661K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.16MShares$226 Million0.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.49MShares$201 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.43MShares$199 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO3.16MShares$116 Million0.08% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.9MShares$106 Million0.03% of portfolio
About Enovis CORP
- Ticker ENOV
- Exchange NYSE
- Sector Industrials
- Industry Specialty Industrial Machinery
- Shares Outstandng 54,129,500
- Market Cap $1.98B
- Description
- Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...